All Articles
Metformin and Diarrhea: Is It Common?
Oct 21, 2024
Metformin has been known to cause diarrhea in patients. In fact, Diarrhea is a well-known adverse and somewhat common side effect when metformin is initiated for type 2 diabetes. However, it usually resolves itself with continued use (or as your body adapts to your new medication). Only a few cases of chronic diarrhea have been reported after...
Read More
Metformin and Prediabetes: What to Know
Oct 14, 2024
Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in the blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. It’s commonly prescribed to help with the treatment of Type-2 diabetes. Early research shows metformin reduces the...
Read More
Maximum Dose of Metformin Per Day (Guide)
Oct 7, 2024
Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in the blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. It’s commonly prescribed to help with the treatment of Type-2 diabetes.Key TakeawaysImmediate-release and...
Read More
Is 500mg Metformin Considered Low Dose?
Sep 30, 2024
“Low dose” metformin is usually considered to be 500mg tablets. Most commonly, 500 milligram tablets are prescribed and produced based on the research and evidence of its effectiveness and efficacy at these levels. AJ Garber’s study on metformin concluded, “compared to placebo, 500mg metformin decreased HbA1c 0.6% and 2000...
Read More
Qulipta and Weight Loss: What to Know
Sep 29, 2024
Qulipta (atogepant) trials showed that patients who took Qulipta against patients who took a placebo experienced a 7% decrease in body weight. More patients experience weight decrease when on the 10 mg prescription (3.8%) than on the 30 mg prescription (3.2%). And oddly, only 5.3% of patients on the 60 mg prescription experienced a weight decrease....
Read More
Qulipta Uses: For Patients with Migraines and More
Sep 23, 2024
Qulipta (atogepant) is a prescription drug used daily for the preventive treatment of episodic migraine (with headaches occurring up to 14 days per month) in adults. Its mechanism, which involves blocking calcitonin gene-related peptide (CGRP) receptors, is focused on preventing the onset of migraine attacks. There are no off-label uses or...
Read More
Qulipta Withdrawal Symptoms: What to Know
Sep 16, 2024
Qulipta (atogepant) is a prescription drug used daily for the preventive treatment of episodic migraine (with headaches occurring up to 14 days per month) in adults. Its mechanism, which involves blocking calcitonin gene-related peptide (CGRP) receptors, is focused on preventing the onset of migraine attacks....
Read More
Qulipta vs Ubrevly: Comparison (Guide)
Sep 9, 2024
Qulipta (atogepant) is a prescription drug used daily for the preventive treatment of episodic migraine (with headaches occurring up to 14 days per month) in adults. Its mechanism, which involves blocking calcitonin gene-related peptide (CGRP) receptors, is focused on preventing the onset of migraine attacks. Ubrevly (ubrogepant) is a calcitonin...
Read More
Qulipta Cost: With and Without Insurance (Guide)
Sep 2, 2024
On average, Qulipta (atogepant) can cost anywhere from $1,299 to $1,490.16 per full supply that’s not covered by insurance. Typically, that’s a 30-day supply of 60 milligram (mg) oral tablets. Insurance coverage for Qulipta can be cumbersome to navigate, since some insurance companies offer coverage and others do not. However, Qulipta...
Read More
